 |
인쇄하기
취소
|
Hepatitis C-type treatment proved 12 weeks consecutive response
SAPPHIRE-II opened 3 phase clinical demonstration for the evaluation of 3D therapy
(Dailypharm)
Hepatitis C-type treatment which is in process of development by Abbvie proved 12 weeks of consecutive treatment efficacy.
Abbvie has recently announced the result of 3 phase clinical demonstration evaluated for the treatment method by adding the Ribavirin and three kinds of anti-viral virus (...
(Dailypharm)
Hepatitis C-type treatment which is in process of development by Abbvie proved 12 weeks of consecutive treatment efficacy.
Abbvie has recently announced the result of 3 phase clinical demonstration evaluated for the treatment method by adding the Ribavirin and three kinds of anti-viral virus (...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.